Aurobindo Pharma Ltd. Fundamental & Technical Research, Share Price Today

NSE : AUROPHARMA
NIFTY : NIFTY Midcap 100
NIFTY SECTOR : Nifty Pharma

About Company

Aurobindo Pharma Limited continues to be one of the world’s fastest growing Active Pharmaceutical Ingredients (API) manufacturing companies, driven by cost leadership, flexibility to produce multiple products in the same manufacturing facilities and capabilities in various therapeutic domains. Its API business has ensured the profitability and growth of its formulations business through seamless vertical integration. Its API business is supported by technologically advanced research and development infrastructure, which develops new products and plays a role in the delivery of products to the market. It has built a strong presence in key therapeutic segments such as Central nervous system (CNS), cardiovascular (CVS), anti-retroviral (ARV), anti-diabetics, gastroenterology and antibiotics. Also, it is building a diversified pipeline in high-margin specialty generic formulations segment.

Market Cap. ₹70,254 Cr.

52 Week - High/Low ₹1,592/1,010

P/E Ratio 36.78

P/B Ratio 3.56

Enterprise Value ₹73,559 Cr.

ROE % 10.06

RSI Value 55.74

EMA 50 1165.6

EMA 200 1214.46

Market Cap. ₹70,254 Cr.

52 Week - High/Low ₹1,592/1,010

P/E Ratio 20.22

P/B Ratio 2.35

Enterprise Value ₹65,784 Cr.

ROE % 11.18

RSI Value 55.74

EMA 50 1165.6

EMA 200 1214.46

Add Parameters

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages